Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-06

Clinical Trial Update: Chronotherapy with Low-dose Aspirin for Primary Prevention [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update studying chronotherapy with low-dose aspirin for primary prevention in adults with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: University of Vigo | Conditions: Type 2 Diabetes | Phase 4 | Status: ACTIVE_NOT_RECRUITING